Jill Konowich MD/PhD

Jill Konowich, MD/PhD, is a Director at Health Innovation Capital, where she plays a significant role in advancing healthcare innovations. With over 12 years of experience in scientific research and clinical medicine, she has a robust background as a physician scientist specializing in radiation oncology, immunology, and infectious diseases.

Education and Background

• MD/PhD: Jill obtained her MD/PhD in Immunology, Infectious Disease, and Microbiology from Rutgers New Jersey Medical School, completing her studies in 2018. Her doctoral research focused on tuberculosis at both preclinical and clinical levels.

• Undergraduate Degree: She earned a Bachelor of Science in Biology from the Massachusetts Institute of Technology (MIT) in 2006.

Professional Experience

Before her current role, Jill has contributed to numerous publications and grant applications and has worked with key opinion leaders in her field. She has transitioned into the life sciences sector of venture capital, aiming to leverage her expertise to impact a broader patient population, particularly in cancer, autoimmunity, and rare diseases.

Current Role

As the Director at Health Innovation Capital, Jill is involved in identifying and evaluating new therapeutic opportunities and translating complex scientific information for various stakeholders, including investors and healthcare professionals.123